Reprogramming of profibrotic macrophages for treatment of bleomycin‐induced pulmonary fibrosis-Reference-Cited by-同舟云学术

Reprogramming of profibrotic macrophages for treatment of bleomycin‐induced pulmonary fibrosis

Published:2020-06-29 Issue:8 Volume:12 Page:
ISSN:1757-4676
Container-title:EMBO Molecular Medicine
language:en
Short-container-title:EMBO Mol Med

Author:

Zhang Fenghua¹^ORCID,Ayaub Ehab A²,Wang Bingbing¹,Puchulu‐Campanella Estela¹^ORCID,Li Yen‐Hsing¹,Hettiarachchi Suraj U¹,Lindeman Spencer D¹,Luo Qian¹,Rout Sasmita¹,Srinivasarao Madduri¹,Cox Abigail³,Tsoyi Konstantin²,Nickerson‐Nutter Cheryl⁴,Rosas Ivan O²,Low Philip S¹^ORCID

Affiliation:

1. Department of Chemistry and Institute for Drug Discovery Purdue University West Lafayette IN USA

2. Division of Pulmonary and Critical Care Medicine Brigham and Women's Hospital Harvard Medical School Boston MA USA

3. Department of Comparative Pathobiology Purdue College of Veterinary Medicine West Lafayette IN USA

4. Three Lakes Partners Northbrook IL USA

Publisher

EMBO

Subject

Molecular Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.15252/emmm.202012034

Reference63 articles.